question: Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?
answer: No. Co-loss of BRCA2-RB1 in human prostate cancer cells induces an epithelial-to-mesenchymal transition, which is associated with invasiveness and a more aggressive disease phenotype.